Citations

Showing 10 of 108104 citations.

Letter to the Editor: Editorial: The Nazi Musculoskeletal Experiments-Why Publish an Article About Them in 2018?
Shi, Glenn G. , Shi, Glenn G

Mayo Clinic

Clinical Orthopaedics & Related Research | November 14, 2018 | Volume: 476 | Issue: 12 | Pages: 2464-2464

10.1097/corr.0000000000000563 | PMID 30427318 Get It

CORR Insights®: What are the Demographics and Epidemiology of Legg-Calvé-Perthes Disease in a Large Southern California Integrated Health System?
Larson, A. Noelle

Mayo Clinic

Clinical Orthopaedics & Related Research | November 14, 2018 | Volume: 476 | Issue: 12 | Pages: 2351-2352

10.1097/corr.0000000000000547 | PMID 30422968 Get It

Clinical management of hypoactive sexual desire disorder
Kingsberg, Sheryl A. , Faubion, Stephanie, Faubion, Stephanie S.

Mayo Clinic

Menopause | November 13, 2018 | Volume: 26 | Issue: 2 | Pages: 217-219

10.1097/gme.0000000000001212 | PMID 30422931 Get It

Abstract Although a woman's healthcare provider has the best opportunity to address hypoactive sexual desire disorder (HSDD), most women are reluctant to discuss their loss of sexual desire. The feeling is often mutual, because limited education and misunderstanding persist, leaving few providers feeling competent to assess and treat this condition. The purpose of this Practice Pearl is to improve the clinician's understanding of and confidence in discussing HSDD, including symptoms, etiology, burden, diagnosis, and treatment.
Procedures to Promote Ethical Open Access Publishing: A Comment to Shaw and Elger
Master, Zubin

Mayo Clinic

Accountability in Research | November 13, 2018 | Volume: 25 | Issue: 7-8 | Pages: 417-418

10.1080/08989621.2018.1547966 | PMID 30421975 Get It

Trends in Patch Testing With the Mayo Clinic Standard Series, 2011–2015
Veverka, Kevin K. , Hall, Matthew R., Yiannias, James A. , Drage, Lisa A., Killian, Jill M. , Johnson, Janis S, Linehan, Diane L. Nordberg, Singh, Nidhi , Davis, Mark D. P. , Nordberg Linehan, Diane L, el‐Azhary, Rokea A. , Davis, Mark D.P.

Mayo Clinic

Dermatitis® | November 13, 2018 | Volume: 29 | Issue: 6 | Pages: 310-315

10.1097/der.0000000000000411 | PMID 30422883 Get It

Background Patch testing to a standard (baseline) series of allergens is the screening tool used to identify culprit allergens in patients with contact dermatitis. The allergens and concentrations used in a standard series are constantly evolving to be most relevant to the patients being patch tested. Objective The aim of this study was to analyze the 2011–2015 patch test results of the Mayo Clinic standard series. Methods We retrospectively reviewed patch test reactions of standard series allergens from 2011 through 2015 and compared these results with the 2011–2012 and 2013–2014 North American Contact Dermatitis Group (NACDG) reports. Conclusions Of 2582 patients included, 1566 (60.7%) had at least 1 positive reaction, and 516 (20.0%) had at least 1 irritant reaction. The 15 allergens with the highest reaction rates (from highest to lowest) were nickel sulfate hexahydrate, methylisothiazolinone, Myroxylon pereirae resin, neomycin sulfate, cobalt (II) chloride hexahydrate, benzalkonium chloride, fragrance mix I, potassium dichromate, bacitracin, methylchloroisothiazolinone/methylisothiazolinone, carba mix, formaldehyde, p -phenylenediamine, quaternium-15, and methyldibromo glutaronitrile. Twelve (80%) of these allergens were also in the top 15 of the most recent NACDG report; the 3 allergens not in the NACDG top 15 allergens were potassium dichromate, benzalkonium chloride, and methyldibromo glutaronitrile (the latter 2 allergens are not included in their series).
Models of Peer Support to Remediate Post-Intensive Care Syndrome: A Report Developed by the Society of Critical Care Medicine Thrive International Peer Support Collaborative*
McPeake, Joanne , Hirshberg, Eliotte L. , Christie, LeeAnn M., Drumright, Kelly, Hough, Catherine L. , Meyer, Joel , Wade, Dorothy , Andrews, Adair, Bakhru, Rita N. , Bates, Samantha , Barwise, John, Beesley, Sarah J. , Boehm, Leanne M. , Brown, Sheryl, Clay, Alison S. , Firshman, Penelope , Greenberg, Steven B. , Harris, Wendy, Hope, Aluko A. , Hopkins, Ramona O., Howell, David C., Jackson, James C. , Johnson, Annie, Kross, Erin K. , Lamas, Daniela, MacLeod-Smith, Belinda, Mandel, Ruth, Marshall, John C., Nackino, Megan, Quasim, Tara , Sevin, Carla M. , Slack, Andrew, Spurr, Rachel, Still, Mary, Thompson, Carol, Weinhouse, Gerald L., Wilcox, M. Elizabeth , Iwashyna, Theodore J. , Haines, Kimberley , Bastarache, Julie A. , Hill, Christopher, Hodgson, Carol Lynette , Holdsworth, Clare, Howell, David C. J., Janssen, Anna, Mikkelsen, Mark E.

Mayo Clinic

Critical Care Medicine | November 13, 2018 | Volume: 47 | Issue: 1 | Pages: e21-e27

10.1097/ccm.0000000000003497 | PMID 30422863 Get It

Objectives: Patients and caregivers can experience a range of physical, psychologic, and cognitive problems following critical care discharge. The use of peer support has been proposed as an innovative support mechanism. Design: We sought to identify technical, safety, and procedural aspects of existing operational models of peer support, among the Society of Critical Care Medicine Thrive Peer Support Collaborative. We also sought to categorize key distinctions between these models and elucidate barriers and facilitators to implementation. Subjects and Setting: Seventeen Thrive sites from the United States, United Kingdom, and Australia were represented by a range of healthcare professionals. Measurements and Main Results: Via an iterative process of in-person and email/conference calls, members of the Collaborative defined the key areas on which peer support models could be defined and compared, collected detailed self-reports from all sites, reviewed the information, and identified clusters of models. Barriers and challenges to implementation of peer support models were also documented. Within the Thrive Collaborative, six general models of peer support were identified: community based, psychologist-led outpatient, models-based within ICU follow-up clinics, online, groups based within ICU, and peer mentor models. The most common barriers to implementation were recruitment to groups, personnel input and training, sustainability and funding, risk management, and measuring success. Conclusions: A number of different models of peer support are currently being developed to help patients and families recover and grow in the postcritical care setting.
Lead Shielding in Pediatric Chest CT: Effect of Apron Placement Outside the Scan Volume on Radiation Dose Reduction
Yu, Lifeng , Bruesewitz, Michael R. , Vrieze, Thomas J., Yu, Lifeng , McCollough, Cynthia H.

Mayo Clinic

American Journal of Roentgenology | November 13, 2018 | Volume: 212 | Issue: 1 | Pages: 151-156

10.2214/ajr.17.19405 | PMID 30422712 Get It

WASH Regulates Glucose Homeostasis by Facilitating Glut2 Receptor Recycling in Pancreatic β-Cells
Han, Lingling , Dubé, John J. , Billadeau, Daniel D. , Dube, John, Billadeau, Daniel D , Ding, Li , Dube, John

Mayo Clinic

Diabetes | November 13, 2018 | Volume: 68 | Issue: 2 | Pages: 377-386

10.2337/db18-0189 | PMID 30425062 Get It

WASH is an endosomal protein belonging to the Wiskott-Aldrich syndrome protein superfamily that participates in endosomal receptor trafficking by facilitating tubule fission via activation of the ubiquitously expressed Arp2/3 complex. While several studies have begun to elucidate an understanding of the functions of WASH in cells lines, the in vivo function of WASH has not been fully elucidated, since total body deletion in mice leads to early embryonic lethality. To circumvent this problem, we have used a WASH conditional knockout mouse model to investigate the role of WASH in the pancreas. We find that pancreas-specific deletion of WASH leads to impaired blood glucose clearance and reduced insulin release upon glucose stimulation. Furthermore, WASH depletion results in impaired trafficking of Glut2 in pancreatic β-cells as a consequence of an intracellular accumulation of Glut2 and overall decreased levels of Glut2 protein. Taken together, these results indicate that WASH participates in pancreatic β-cell glucose sensing and whole-body glucose homeostasis. Thus, patients harboring mutations in components of the WASH complex could be at risk for developing type 2 diabetes.
Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction
Obokata, Masaru , Reddy, Yogesh N.V. , Pislaru, Sorin V. , Borlaug, Barry A. , Melenovský, Vojtěch , Pislaru, Sorin, Sabbah, Michael S. , Nishimura, Rick , Borlaug, Barry A , Obokata, Masaru

Mayo Clinic

European Heart Journal | November 13, 2018 | Volume: 40 | Issue: 8 | Pages: 689-697

10.1093/eurheartj/ehy809 | PMID 30544228 Get It

Abstract Aims Prevalent right ventricular (RV) dysfunction (RVD) is associated with increased mortality in patients with heart failure with preserved ejection fraction (HFpEF), but no study has characterized long-term changes in RV structure and function within the same patient. Methods and results Patients with unequivocal HFpEF defined by either invasive haemodynamics or hospitalization for pulmonary oedema (n = 271) underwent serial echocardiographic evaluations >6 months apart. Clinical, structural, functional, and haemodynamic characteristics were examined. Over a median of 4.0 years (interquartile range 2.1–6.1), there was a 10% decline in RV fractional area change and 21% increase in RV diastolic area (both P < 0.0001). These changes greatly exceeded corresponding changes in the left ventricle. The prevalence of tricuspid regurgitation increased by 45%. Of 238 patients with normal RV function at Exam 1, 55 (23%) developed RVD during follow-up. Development of RVD was associated with both prevalent and incident atrial fibrillation (AF), higher body weight, coronary disease, higher pulmonary artery and left ventricular filling pressures, and RV dilation. Patients with HFpEF developing incident RVD had nearly two-fold increased risk of death (adjusted hazard ratio 1.89, 95% confidence interval 1.01–3.44; P = 0.04). Conclusion While previous attention has centred on the left ventricle in HFpEF, these data show that right ventricular structure and function deteriorate to greater extent over time when compared with changes in the left ventricle. Further study is required to evaluate whether interventions targeting modifiable risk factors identified for incident RVD, including abnormal haemodynamics, AF, coronary disease, and obesity, can prevent RVD and thus improve outcomes.
Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer
Elhanafi, Sherif , Mahmud, Nadim , Vergara, Norge, Kochman, Michael L. , Das, Koushik K. , Ginsberg, Gregory G. , Rajala, Michael W., Chandrasekhara, Vinay

Mayo Clinic

Journal of Gastroenterology and Hepatology | November 13, 2018 | Volume: 34 | Issue: 5 | Pages: 907-913

10.1111/jgh.14540 | PMID 30422342 Get It

AbstractBackground and AimTumor genotyping may allow for improved prognostication and targeted therapy for pancreatic ductal adenocarcinoma (PDAC). We aimed to compare endoscopic ultrasonography (EUS) with fine needle aspiration (FNA) to fine needle biopsy (FNB) for obtaining sufficient tissue for genomic analysis and theranostic potential.MethodsA retrospective cohort study of patients that underwent EUS‐FNA or EUS‐FNB with either positive or suspicious cytology for PDAC between March 2016 and December 2017. Demographic, procedural, and cytology data were recorded. Genetic alterations were recorded, and Kaplan–Meier survival curves were calculated.ResultsThe study included 167 patients: 145 patients had FNA and 22 patients underwent FNB. Overall, 117 samples (70.1%) were sufficient for targeted next‐generation sequencing. FNB resulted in a higher proportion of patients with sufficient samples compared with FNA (90.9% vs 66.9%; P = 0.02). In multivariable modeling, only FNB (odds ratio 4.95, 95% confidence interval 1.11–22.05, P = 0.04) was associated with sufficient sampling for genomic testing. FNB was more likely to obtain sufficient tissue from tumors ≤ 3 cm (100% vs 68.4%, P = 0.017) and tumors located in the head/neck of the pancreas (100% vs 63.1%, P = 0.03) compared with FNA. The most commonly identified alterations were in KRAS (88%), TP53 (68%), and SMAD4 (16%).ConclusionsEndoscopic ultrasonography can reliably obtain sufficient tissue from PDAC for targeted genomic sequencing for prognostication and theranostics. FNB should be considered when tumor genotyping is requested, especially for tumors ≤ 3 cm or tumors located in the head/neck of the pancreas.